Axovant Announces First Parkinson’s Disease Gene Therapy R&D Day and Participation in Upcoming September Conferences”
– Parkinson’s Disease R&D Day to be hosted by Gavin Corcoran, MD, Chief R&D Officer, on October 30th, […]
ICU Medical, Inc. to Present at Morgan Stanley 18th Annual Global Healthcare Conference
SAN CLEMENTE, Calif., Sept. 08, 2020 (GLOBE NEWSWIRE) — ICU Medical, Inc. (Nasdaq:ICUI), a leader in the development, manufacture and […]
OpGen Group Company Ares Genetics Nominated for Austrian Innovation Award for AI-powered Molecular Antibiotic Susceptibility Test
Ares Genetics nominated for the 40th Austrian Innovation Award by Federal Ministry for Digital and Economic AffairsARESupa – Universal Pathogenome […]
Translate Bio Resumes Enrollment and Dosing in Phase 1/2 Clinical Trial of MRT5005 in Cystic Fibrosis
LEXINGTON, Mass., Sept. 08, 2020 (GLOBE NEWSWIRE) — Translate Bio (Nasdaq: TBIO), a clinical-stage messenger RNA (mRNA) therapeutics company developing […]
New Biogen Data Presented at ACTRIMS-ECTRIMS Advance Understanding of Clinical and Health Disparities in MS
Data highlights socio-demographic and clinical disparities to help raise awareness of health inequities and inform future treatment planningReal-world data from […]
Revolution Medicines to Participate in 2nd Annual RAS-Targeted Drug Development Conference
REDWOOD CITY, Calif., Sept. 08, 2020 (GLOBE NEWSWIRE) — Revolution Medicines, Inc. (Nasdaq: RVMD), a clinical-stage precision oncology company focused […]
Spero Therapeutics Announces Positive Topline Results from its Phase 3 ADAPT-PO Clinical Trial of Oral Tebipenem HBr in Complicated Urinary Tract Infection and Acute Pyelonephritis
Pivotal Phase 3 clinical trial of oral tebipenem HBr met primary endpoint, demonstrating statistical non-inferiority versus intravenous ertapenem in patients […]
TSX News -
Marathon Gold Reports Additional Exploration Drill Results from the Valentine Gold Project
TORONTO, Sept. 08, 2020 (GLOBE NEWSWIRE) — Marathon Gold Corporation (“Marathon” or the “Company”; TSX: MOZ) is pleased to report […]
REPEAT – Developing Patent Portfolio: Taat Completes Filing of its First U.S. Patent for Beyond Tobacco™ Base Material Refinement Process
In preparation for launching Beyond Tobacco™ cigarettes, which is set to take place in Q4 2020, the Company has completed […]
Blueberries Medical to Webcast Live at VirtualInvestorConferences.com on September 10th
TORONTO, Sept. 08, 2020 (GLOBE NEWSWIRE) — Blueberries Medical Corp. (CSE:BBM) (OTCQB: BBRRF) (FRA: 1OA), (the “Company” or “Blueberries“), a […]
